<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiotomsk</journal-id><journal-title-group><journal-title xml:lang="ru">Сибирский журнал клинической и экспериментальной медицины</journal-title><trans-title-group xml:lang="en"><trans-title>Siberian Journal of Clinical and Experimental Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2713-2927</issn><issn pub-type="epub">2713-265X</issn><publisher><publisher-name>TSU publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.29001/2073-8552-2021-36-3-59-67</article-id><article-id custom-type="elpub" pub-id-type="custom">cardiotomsk-1245</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL STUDIES</subject></subj-group></article-categories><title-group><article-title>Уровень продукции активных форм кислорода адипоцитами эпикардиальной жировой ткани у пациентов с выраженным коронарным атеросклерозом взаимосвязан с возрастанием постпрандиальной гликемии</article-title><trans-title-group xml:lang="en"><trans-title>The level of reactive oxygen species production by adipocytes of epicardial adipose tissue is associated with an increase in postprandial glycemia in patients with severe coronary atherosclerosis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6679-1269</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кошельская</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Koshelskaya</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кошельская Ольга Анатольевна - доктор медицинских наук, профессор, ведущий научный сотрудник, отделение атеросклероза и хронической ишемической болезни сердца.</p><p>634012, Томск, ул. Киевская, 111а</p></bio><bio xml:lang="en"><p>Olga A. Koshelskaya, Dr. Sci. (Med.), Professor, Leading Research Scientist, Department of Atherosclerosis and Coronary Artery Disease.</p><p>111a, Kievskaya str., Tomsk, 634012</p></bio><email xlink:type="simple">koshel@live.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2264-1928</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нарыжная</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Naryzhnaya</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Нарыжная Наталья Владимировна - доктор медицинских наук, ведущий научный сотрудник, лаборатория экспериментальной кардиологии.</p><p>634012, Томск, ул. Киевская, 111а</p></bio><bio xml:lang="en"><p>Natalia V. Naryzhnaya, Dr. Sci. (Med.), Leading Research Scientist, Laboratory of Experimental Cardiology.</p><p>111a, Kievskaya str., Tomsk, 634012</p></bio><email xlink:type="simple">natalynar@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4537-0008</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кологривова</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kologrivova</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кологривова Ирина Вячеславовна - кандидат медицинских наук, научный сотрудник, отделение функциональной и лабораторной диагностики.</p><p>634012, Томск, ул. Киевская, 111а</p></bio><bio xml:lang="en"><p>Irina V. Kologrivova, Cand. Sci. (Med.), Research Scientist, Department of Clinical Laboratory Diagnostics.</p><p>111a, Kievskaya str., Tomsk, 634012</p></bio><email xlink:type="simple">ikologrivova@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9645-6720</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Суслова</surname><given-names>Т. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Suslova</surname><given-names>T. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Суслова Татьяна Евгеньевна - кандидат медицинских наук, старший ведущий научный сотрудник, отделение функциональной и лабораторной диагностики.</p><p>634012, Томск, ул. Киевская, 111а</p></bio><bio xml:lang="en"><p>Tatiana E. Suslova, Cand. Sci. (Med.), Head of the Department, Department of Clinical Laboratory Diagnostics.</p><p>111a, Kievskaya str., Tomsk, 634012</p></bio><email xlink:type="simple">tes@cardio-tomsk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2818-5882</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Харитонова</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kharitonova</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Харитонова Ольга Анатольевна - лаборант-исследователь, отделение атеросклероза и хронической ишемической болезни сердца.</p><p>634012, Томск, ул. Киевская, 111а</p></bio><bio xml:lang="en"><p>Olga A. Haritonova, Research Assistant, Department of Atherosclerosis and Coronary Artery Disease.</p><p>111a, Kievskaya str., Tomsk, 634012</p></bio><email xlink:type="simple">hoa@cardio-tomsk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5537-0864</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Евтушенко</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Evtushenko</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Евтушенко Владимир Валерьевич - доктор медицинских наук, врач отделения сердечно-сосудистой хирургии.</p><p>634012, Томск, ул. Киевская, 111а</p></bio><bio xml:lang="en"><p>Vladimir V. Evtushenko, Dr. Sci. (Med.), Cardiovascular Surgeon, Department of Cardiovascular Surgery No. 1.</p><p>111a, Kievskaya str., Tomsk, 634012</p></bio><email xlink:type="simple">Evtushenko.vladimir@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4049-8715</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Андреев</surname><given-names>С. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Andreev</surname><given-names>S. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Андреев Сергей Леонидович - кандидат медицинских наук, старший научный сотрудник, отделение сердечно-сосудистой хирургии.</p><p>634012, Томск, ул. Киевская, 111а</p></bio><bio xml:lang="en"><p>Sergey L. Andreev - Cand. Sci. (Med.), Senior Research Scientist, Department of Cardiovascular Surgery No. 1.</p><p>111a, Kievskaya str., Tomsk, 634012</p></bio><email xlink:type="simple">anselen@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5890-071X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Горбунов</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Gorbunov</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Горбунов Александр Сергеевич - кандидат медицинских наук, старший научный сотрудник, лаборатория экспериментальной кардиологии.</p><p>634012, Томск, ул. Киевская, 111а</p></bio><bio xml:lang="en"><p>Alexander S. Gorbunov, Cand. Sci. (Med), Senior Research Scientist, Laboratory of Experimental Cardiology.</p><p>111a, Kievskaya str., Tomsk, 634012</p></bio><email xlink:type="simple">barabator@sibmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7050-2212</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гудкова</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Gudkova</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гудкова Анастасия Алексеевна - студентка.</p><p>634050, Томск, Московский тракт, 2</p></bio><bio xml:lang="en"><p>Anastasia A. Gudkova, Medical Student.</p><p>2, Moskovsky tract, Tomsk, 634050</p></bio><email xlink:type="simple">anastasia_gudkova98@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научно-исследовательский институт кардиологии, Томский национальный исследовательский медицинский центр Российская академия наук</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Сибирский государственный медицинский университет Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Siberian State Medical University,</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>06</day><month>10</month><year>2021</year></pub-date><volume>36</volume><issue>3</issue><fpage>59</fpage><lpage>67</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кошельская О.А., Нарыжная Н.В., Кологривова И.В., Суслова Т.Е., Харитонова О.А., Евтушенко В.В., Андреев С.Л., Горбунов А.С., Гудкова А.А., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Кошельская О.А., Нарыжная Н.В., Кологривова И.В., Суслова Т.Е., Харитонова О.А., Евтушенко В.В., Андреев С.Л., Горбунов А.С., Гудкова А.А.</copyright-holder><copyright-holder xml:lang="en">Koshelskaya O.A., Naryzhnaya N.V., Kologrivova I.V., Suslova T.E., Kharitonova O.A., Evtushenko V.V., Andreev S.L., Gorbunov A.S., Gudkova A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.sibjcem.ru/jour/article/view/1245">https://www.sibjcem.ru/jour/article/view/1245</self-uri><abstract><p>До настоящего времени механизмы окислительного стресса адипоцитов локальных жировых депо у пациентов с кардиометаболическими заболеваниями исследованы в недостаточной степени.</p><sec><title>Цель исследования</title><p>Цель исследования: изучить уровень продукции активных форм кислорода (АФК) в адипоцитах эпикардиальной (ЭЖТ) и подкожной жировых тканей (ПЖТ) у пациентов со стабильной ишемической болезнью (ИБС) и выраженным коронарным атеросклерозом, исследовать потенциальные связи уровней выработки АФК адипоцитами ЭЖТ и ПЖТ с показателями ожирения, накоплением ЭЖТ, гликемией, дислипидемией.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. В исследование включены 19 пациентов (12 мужчин и 7 женщин, 6 пациентов (31,5%) с сахарным диабетом 2-го типа) в возрасте 53–72 лет со стабильной ИБС и выраженным коронарным атеросклерозом, у которых имелись показания для проведения хирургической операции аортокоронарного шунтирования. Материалом для исследования служили адипоциты ЭЖТ и ПЖТ, полученные ферментативным методом из интраоперационных эксплантов. Уровень АФК в адипоцитах определяли флуориметрически с помощью красителя 2,3-дигидродихлорфлуоресцеина диацетата. Оценивали антропометрические показатели ожирения и рассчитывали толщину ЭЖТ (тЭЖТ) с помощью эхокардиографии. Изучали состояние липидтранспортной функции крови и уровни базальной и поспрандиальной глюкозы (ППГ).</p></sec><sec><title>Результаты</title><p>Результаты. Уровни выработки АФК адипоцитами ЭЖТ и ПЖТ в общей группе пациентов значимо не различались и составили 1710 (1608; 2079) и 1876 (1374; 2215) усл. ед. соответственно. Уровень продукции АФК адипоцитами ПЖТ не имел корреляционных связей с показателями ожирения, тЭЖТ и содержанием в крови изученных биомаркеров. Уровень выработки АФК в адипоцитах ЭЖТ демонстрировал прямую корреляционную взаимосвязь со значениями ППГ (rs = 0,62; p &lt; 0,05), но не с показателями общего и абдоминального ожирения, тЭЖТ и дислипидемией. Установлено, что у пациентов со значениями ППГ ≥ 7,7 ммоль/л уровень продукции АФК адипоцитами ЭЖТ (n = 9) превышал таковой у пациентов с более низким уровнем ППГ (n = 10): 2079 (1710; 2458) против 1625,5 (1332; 1699) усл. ед. (p = 0,015) соответственно.</p></sec><sec><title>Заключение</title><p>Заключение. Наши данные впервые показывают, что уровень продукции АФК адипоцитами ЭЖТ у пациентов с хронической ИБС и выраженным коронарным атеросклерозом имеет прямую связь с содержанием в крови ППГ. Наиболее высокий уровень выработки АФК в адипоцитах ЭЖТ у этой категории пациентов имеет место при уровне ППГ более 7,7 ммоль/л.</p></sec></abstract><trans-abstract xml:lang="en"><p>The mechanisms of oxidative stress in adipocytes of local fat depots in patients with cardiometabolic diseases have been studied insufficiently.</p><sec><title>Purpose</title><p>Purpose. To study the levels of reactive oxygen species (ROS) production in adipocytes of epicardial (EAT) and subcutaneous adipose tissue (SAT) in patients with stable coronary artery disease (CAD) and severe coronary atherosclerosis who underwent coronary artery bypass grafting; to investigate the potential relationships between the levels of ROS production by EAT and SAT adipocytes and obesity parameters, EAT accumulation, basal and postprandial glycemia, and blood lipid transport function.</p></sec><sec><title>Material and Methods</title><p>Material and Methods. The study included 19 patients (12 men and 7 women including 6 patients (31.5%) with type 2 diabetes mellitus) aged 53–72 years with stable CAD and severe coronary atherosclerosis. The material for the study was EAT and SAT adipocytes obtained by the enzymatic method from intraoperative explants. The ROS level in adipocytes was determined using the fluorimetry with 2,3-dihydrodichlorofluorescein diacetate. Anthropometric parameters of obesity and EAT thickness were studied using echocardiography. The blood lipid transport function and the levels of basal and postprandial glucose were assessed.</p></sec><sec><title>Results</title><p>Results. The levels of ROS production by EAT and SAT adipocytes in the overall group of patients did not differ significantly and amounted to 1710 (1608; 2079) and 1876 (1374; 2215) arbitrary units, respectively. The level of ROS production by SAT adipocytes did not correlate with the parameters of obesity, EAT thickness, or biomarker levels. The level of ROS production by EAT adipocytes directly correlated with the level of postprandial glycemia (rs = 0.62, p &lt; 0.05), but did not correlate with measures of general and abdominal obesity, EAT thickness, and dyslipidemia. The level of ROS production by EAT adipocytes in patients with postprandial glycemia ≥ 7.7 mmol/L (n = 9) exceeded the corresponding value in patients with lower level of postprandial glycemia (n = 10): 2079 (1710; 2458) against 1625.5 (1332; 1699) arbitrary units (p = 0.015), respectively.</p></sec><sec><title>Conclusion</title><p>Conclusion. We showed for the first time that the level of ROS production by EAT adipocytes in CAD patients with severe coronary atherosclerosis was directly associated with the level of postprandial glycemia. The highest level of ROS production in EAT adipocytes occurred in these patients when the level of postprandial glycemia exceeds 7.7 mmol/L.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>активные формы кислорода</kwd><kwd>адипоциты</kwd><kwd>эпикардиальная жировая ткань</kwd><kwd>постпрандиальная гликемия</kwd><kwd>коронарный атеросклероз</kwd></kwd-group><kwd-group xml:lang="en"><kwd>reactive oxygen species</kwd><kwd>adipocytes</kwd><kwd>epicardial adipose tissue</kwd><kwd>postprandial glycemia</kwd><kwd>coronary atherosclerosis</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Тема фундаментальных научных исследований по государственному заданию АААА-А15-115123110026-3</funding-statement><funding-statement xml:lang="en">The study was carried out in the framework of the fundamental research No. AAAA-A15-115123110026-3</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Naka jima Y. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 2004;114(12):1752–1761. DOI: 10.1172/JCI21625.</mixed-citation><mixed-citation xml:lang="en">Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Naka jima Y. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 2004;114(12):1752–1761. DOI: 10.1172/JCI21625.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Wonisch W., Falk A., Sundl I., Winklhofer-Roob B.M., Lindschinger M. Oxidative stress increases continuously with BMI and age with unfavourable profiles in males. Aging Male. 2012;15(3):159–165. DOI: 10.3109/13685538.2012.66943.</mixed-citation><mixed-citation xml:lang="en">Wonisch W., Falk A., Sundl I., Winklhofer-Roob B.M., Lindschinger M. Oxidative stress increases continuously with BMI and age with unfavourable profiles in males. Aging Male. 2012;15(3):159–165. DOI: 10.3109/13685538.2012.66943.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Hatami M., Saidijam M., Yadegarzari R. Peroxisome proliferator-activated receptor-γgene expression and its association with oxida tive stress in patients with metabolic syndrome. Chonnam Med. J. 2016;52(3):201−206. DOI: 10.4068/cmj.2016.52.3.201.</mixed-citation><mixed-citation xml:lang="en">Hatami M., Saidijam M., Yadegarzari R. Peroxisome proliferator-activated receptor-γgene expression and its association with oxida tive stress in patients with metabolic syndrome. Chonnam Med. J. 2016;52(3):201−206. DOI: 10.4068/cmj.2016.52.3.201.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Prokudina E.S., Maslov L.N., Ivanov V.V., Bespalova I.D., Pismennyi D.S., Voronkov N.S. The role of reactive oxygen species in the pathogenesis of adipocyte dysfunction in metabolic syndrome. Prospects of pharmacological correction. Annals of the Russian Academy of Medical Sciences. 2017;72(1):11–16. DOI: 10.15690/vramn798.</mixed-citation><mixed-citation xml:lang="en">Prokudina E.S., Maslov L.N., Ivanov V.V., Bespalova I.D., Pismennyi D.S., Voronkov N.S. The role of reactive oxygen species in the pathogenesis of adipocyte dysfunction in metabolic syndrome. Prospects of pharmacological correction. Annals of the Russian Academy of Medical Sciences. 2017;72(1):11–16. DOI: 10.15690/vramn798.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Maslov L.N., Naryzhnaya N.V., Boshchenko A.A., Popov S.V., Ivanov V.V., Oeltgen P.R. Is oxidative stress of adipocytes a cause or a consequence of the metabolic syndrome? J. Clin. Transl. Endocrinol. 2019;15:1–5. DOI: 10.1016/j.jcte.2018.11.001.</mixed-citation><mixed-citation xml:lang="en">Maslov L.N., Naryzhnaya N.V., Boshchenko A.A., Popov S.V., Ivanov V.V., Oeltgen P.R. Is oxidative stress of adipocytes a cause or a consequence of the metabolic syndrome? J. Clin. Transl. Endocrinol. 2019;15:1–5. DOI: 10.1016/j.jcte.2018.11.001.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Talior I., Yarkoni M., Bashan N., Eldar-Finkelman H. Increased glucose uptake promotes oxidative stress and PKC-δ activation in adipocytes of obese, insulin-resistant mice. Am. J. Physiol. Endocrinol. Metab. 2003;285(2):E295−E302. DOI: 10.1152/ajpendo.00044.2003.</mixed-citation><mixed-citation xml:lang="en">Talior I., Yarkoni M., Bashan N., Eldar-Finkelman H. Increased glucose uptake promotes oxidative stress and PKC-δ activation in adipocytes of obese, insulin-resistant mice. Am. J. Physiol. Endocrinol. Metab. 2003;285(2):E295−E302. DOI: 10.1152/ajpendo.00044.2003.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Консенсус российских экспертов по проблеме метаболического синдрома в Российской Федерации: определение, диагностические критерии, первичная профилактика и лечение. Профилактическая медицина. 2010;13(5):27−32.</mixed-citation><mixed-citation xml:lang="en">Russian experts’ consensus on metabolic syndrome problem in the Russian Federation: definition, diagnostic criteria, primary prevention, and treatment. Preventive Medicine. 2010;13(5):27−32 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Thalmann S., Juge-Aubry C.E., Meier C.A. Explant cultures of white adipose tissue. In: adipose tissue protocols. Methods Mol. Biol. 2008;456:195−199. DOI: 10.1007/978-1-59745-245-8_14.</mixed-citation><mixed-citation xml:lang="en">Thalmann S., Juge-Aubry C.E., Meier C.A. Explant cultures of white adipose tissue. In: adipose tissue protocols. Methods Mol. Biol. 2008;456:195−199. DOI: 10.1007/978-1-59745-245-8_14.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Suga H., Matsumoto D., Inoue K., Shigeura T., Eto H., Aoi N. et al. Numerical measurement of viable and nonviable adipocytes and oth er cellular components in aspirated fat tissue. Plast. Reconstr. Surg. 2008;122(1):103–114. DOI: 10.1097/PRS.0b013e31817742ed.</mixed-citation><mixed-citation xml:lang="en">Suga H., Matsumoto D., Inoue K., Shigeura T., Eto H., Aoi N. et al. Numerical measurement of viable and nonviable adipocytes and oth er cellular components in aspirated fat tissue. Plast. Reconstr. Surg. 2008;122(1):103–114. DOI: 10.1097/PRS.0b013e31817742ed.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Jacobellis G., Assael F., Ribaudo M.C. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes. Res. 2003;11(2):304−310. DOI: 10.1038/oby.2003.45.</mixed-citation><mixed-citation xml:lang="en">Jacobellis G., Assael F., Ribaudo M.C. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes. Res. 2003;11(2):304−310. DOI: 10.1038/oby.2003.45.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Sies H. Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: oxidative eustress. Redox Biol. 2017;11:613– 619. DOI: 10.1016/j.redox.2016.12.035.</mixed-citation><mixed-citation xml:lang="en">Sies H. Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: oxidative eustress. Redox Biol. 2017;11:613– 619. DOI: 10.1016/j.redox.2016.12.035.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Lee H., Lee Y.J., Choi H., Ko E.H., Kim J. W. Reactive oxygen spe cies facilitate adipocyte differentiation by accelerating mitotic clonal expansion. J. Biol. Chem. 2009;284(16):10601−10609. DOI: 10.1074/jbc.M808742200.</mixed-citation><mixed-citation xml:lang="en">Lee H., Lee Y.J., Choi H., Ko E.H., Kim J. W. Reactive oxygen spe cies facilitate adipocyte differentiation by accelerating mitotic clonal expansion. J. Biol. Chem. 2009;284(16):10601−10609. DOI: 10.1074/jbc.M808742200.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kono T., Robinson F.W., Blevins T.L., Ezaki O. Evidence that translocation of the glucose transport activity is the major mechanism of insulin action on glucose transport in fat cells. J. Biol. Chem. 1982;257(18):10942−10947. DOI: 10.1016/S0021-9258(18)33914-0.</mixed-citation><mixed-citation xml:lang="en">Kono T., Robinson F.W., Blevins T.L., Ezaki O. Evidence that translocation of the glucose transport activity is the major mechanism of insulin action on glucose transport in fat cells. J. Biol. Chem. 1982;257(18):10942−10947. DOI: 10.1016/S0021-9258(18)33914-0.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">May J.M., de Haen C. Insulin-stimulated intracellular hydrogen peroxide production in rat epididymal fat cells. J. Biol. Chem. 1979;254(7):2214−2220. DOI: 10.1016/S0021-9258(17)30209-0.</mixed-citation><mixed-citation xml:lang="en">May J.M., de Haen C. Insulin-stimulated intracellular hydrogen peroxide production in rat epididymal fat cells. J. Biol. Chem. 1979;254(7):2214−2220. DOI: 10.1016/S0021-9258(17)30209-0.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Little S.A., de Haen C. Effects of hydrogen peroxide on basal and hormonestimulated lipolysis in perifused rat fat cells in relation to the mechanism of action of insulin. J. Biol. Chem. 1980;255(22):10888−10895. DOI: 10.1016/S0021-9258(19)70390-1.</mixed-citation><mixed-citation xml:lang="en">Little S.A., de Haen C. Effects of hydrogen peroxide on basal and hormonestimulated lipolysis in perifused rat fat cells in relation to the mechanism of action of insulin. J. Biol. Chem. 1980;255(22):10888−10895. DOI: 10.1016/S0021-9258(19)70390-1.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Loh K., Deng H., Fukushima A., Cai X., Boivin B., Galic S. et al. Reactive oxygen species enhance insulin sensitivity. Cell Metab. 2009;10(4):260−272. DOI: 10.1016/j.cmet.2009.08.009.</mixed-citation><mixed-citation xml:lang="en">Loh K., Deng H., Fukushima A., Cai X., Boivin B., Galic S. et al. Reactive oxygen species enhance insulin sensitivity. Cell Metab. 2009;10(4):260−272. DOI: 10.1016/j.cmet.2009.08.009.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Salgado-Somoza A., Teijera-Fernández E., Luis Fernández Á., Ramón González-Juanatey J., Eiras S. Proteomic analysis of epicardial and subcutaneous adipose tissue reveals differences in proteins involved in oxidative stress. Am. J. Physiol. Heart Circ. Physiol. 2010;299(1):H202– H209. DOI: 10.1152/ajpheart.00120.2010.</mixed-citation><mixed-citation xml:lang="en">Salgado-Somoza A., Teijera-Fernández E., Luis Fernández Á., Ramón González-Juanatey J., Eiras S. Proteomic analysis of epicardial and subcutaneous adipose tissue reveals differences in proteins involved in oxidative stress. Am. J. Physiol. Heart Circ. Physiol. 2010;299(1):H202– H209. DOI: 10.1152/ajpheart.00120.2010.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Dozio E., Vianello E., Briganti S., Fink B., Malavazos A.E., Scognamiglio E.T. et al. Increased reactive oxygen species production in epicardial adipose tissues from coronary artery disease patients is associated with brown-to-white adipocyte trans-differentiation. Int. J. Cardiol. 2014;174(2):413–414. DOI: 10.1016/j.ijcard.2014.04.045.</mixed-citation><mixed-citation xml:lang="en">Dozio E., Vianello E., Briganti S., Fink B., Malavazos A.E., Scognamiglio E.T. et al. Increased reactive oxygen species production in epicardial adipose tissues from coronary artery disease patients is associated with brown-to-white adipocyte trans-differentiation. Int. J. Cardiol. 2014;174(2):413–414. DOI: 10.1016/j.ijcard.2014.04.045.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Volpe C.M.O., Villar-Delfino P.H., dos Anjos P.M.F. Cellular death, reactive oxygen species (ROS) and diabetic complications. Cell Death Dis. 2018;9(2):119. DOI: 10.1038/s41419-0170135-z.</mixed-citation><mixed-citation xml:lang="en">Volpe C.M.O., Villar-Delfino P.H., dos Anjos P.M.F. Cellular death, reactive oxygen species (ROS) and diabetic complications. Cell Death Dis. 2018;9(2):119. DOI: 10.1038/s41419-0170135-z.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Han C.Y. Roles of reactive oxygen species on insulin resistance in adipose tissue. Diabetes Metab. J. 2016;40(4):272−279. DOI: 10.4093/ dmj.2016.40.4.272.</mixed-citation><mixed-citation xml:lang="en">Han C.Y. Roles of reactive oxygen species on insulin resistance in adipose tissue. Diabetes Metab. J. 2016;40(4):272−279. DOI: 10.4093/ dmj.2016.40.4.272.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Monickaraj F., Aravind S., Nandhini P. Accelerated fat cell aging links oxidative stress and insulin resistance in adipocytes. J. Biosci. 2013;38(1):113−122. DOI: 10.1007/s12038-012-9289-0.</mixed-citation><mixed-citation xml:lang="en">Monickaraj F., Aravind S., Nandhini P. Accelerated fat cell aging links oxidative stress and insulin resistance in adipocytes. J. Biosci. 2013;38(1):113−122. DOI: 10.1007/s12038-012-9289-0.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Houstis N., Rosen E.D., Lander E.S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature. 2006;440(7086):944−948. DOI: 10.1038/nature04634.</mixed-citation><mixed-citation xml:lang="en">Houstis N., Rosen E.D., Lander E.S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature. 2006;440(7086):944−948. DOI: 10.1038/nature04634.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
